Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients

Teresa Amaral; Felix Kiecker; Sarah Schaefer; Henner Stege; Katharina Kaehler; Patrick Terheyden; Anja Gesierich; Ralf Gutzmer; Sebastian Haferkamp; Jochen Uttikal; Carola Berking; David Rafei-Shamsabadi; Lydia Reinhardt; Friedegund Meier; Ante Karoglan; Christian Posch; Thilo Gambichler; Claudia Pfoehler; Kai Thoms; Julia Tietze; Dirk Debus; Rudolf Herbst; Steffen Emmert; Carmen Loquai; Jessica C Hassel; Frank Meiss; Thomas Tueting; Vanessa Heinrich; Thomas Eigentler; Claus Garbe; Lisa Zimmer

doi:10.1136/jitc-2019-000333

Citation Tools

PDF

XML

Clinical/translational cancer immunotherapy

Original research

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Amaral T, Kiecker F, Schaefer S *German Dermatological Cooperative Oncology Group, et al

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients

Journal for ImmunoTherapy of Cancer 2020;8:e000333. doi: 10.1136/jitc-2019-000333

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password